[Federal Register Volume 62, Number 182 (Friday, September 19, 1997)]
[Notices]
[Page 49248]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-24884]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Diabetes and Digestive and Kidney Diseases 
Special Emphasis Panel meeting:

    Name of SEP: HLA Genotyping.
    Date: October 8, 1997.
    Time: 3:00 p.m.
    Contact Person: William Elzinga, Ph.D., Scientific Review 
Administrator, Review Branch, NIDDK, Natcher Building, Room 6as-37A, 
National Institutes of Health, Bethesda, Maryland 20892-6600, Phone: 
(301) 594-8895.
    Purpose/Agenda: To review and evaluate grant applications.
    This meeting will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program No. 93.847-849, 
Diabetes, Endocrine and Metabolic Diseases; Digestive Diseases and 
Nutrition; and Kidney Diseases, Urology and Hematology Research, 
National Institutes of Health)

    Dated: September 12, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-24884 Filed 9-18-97; 8:45 am]
BILLING CODE 4140-01-M